Acton

Acton medical device manufacturer Insulet has made a number of changes to its board, including the retirement of its former leader.

Fundraising continues to grow, with donors and foundations contributing nearly $1.4 million in 2023 for operating support and special projects. That’s up from $1 million in 2020, and $286,000 the year before Beam arrived to lead development.

People are on the move at UMass Memorial Medical Group, MutualOne Bank, and Boston BioProducts.

The Department of Energy Resources gave seven communities the final green light to begin a groundbreaking experiment: they will require new construction and major renovation to embrace fossil fuel-free infrastructure for uses like heating and cooling.

After hinting at a corporate restructuring in November, Psychemedics, an Acton-based manufacturer of hair drug testing kits, has announced it is moving their corporate headquarters to Dallas, Texas.

Bluejay Diagnostics in Acton is launching a clinical trial to study the efficacy of its Symphony System in patients with sepsis, a life-threatening complication from infection.

Governor Maura Healey’s Administration issued $19 million this year in funding from the state’s Workforce Training Funding Program through October, a number including more than $3.9 million in support of training for 2,500+ jobs in Central Massachusetts.

A property in Sutton containing flex warehouse space has been sold for $3.1 million to a Concord-based corporation.

Psychemedics, an Acton-based manufacturer of drug testing kits, has hired Daniella Mehalik as the company’s vice president of finance.

Following a $2.1-million loss in the third quarter, Acton drug testing firm Psychemedics said on Thursday it is in the midst of a restructuring.